Oric Pharmaceuticals, Inc. (ORIC) Free cash flow 2018–2025
Oric Pharmaceuticals, Inc. (ORIC) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$111.7MFY2025 · since FY2018: -$21.2M → -$111.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$111.7M | +1.9% |
| FY2024 | -$113.8M | -31.6% |
| FY2023 | -$86.5M | -12.1% |
| FY2022 | -$77.2M | -27.7% |
| FY2021 | -$60.5M | -31.7% |
| FY2020 | -$45.9M | -89.0% |
| FY2019 | -$24.3M | -14.6% |
| FY2018 | -$21.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice